Neurocrine Biosciences
NBIX
#1377
Rank
โ‚น1.421 T
Marketcap
โ‚น14,047
Share price
-3.84%
Change (1 day)
14.72%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2026 (TTM): โ‚น652.87

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น650.27. In 2025 the company made an earnings per share (EPS) of โ‚น449.68 an increase over its 2024 EPS that were of โ‚น315.34.

EPS history for Neurocrine Biosciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น652.8745.19%
2025โ‚น449.6842.6%
2024โ‚น315.3433.07%
2023โ‚น236.9757.76%
2022โ‚น150.2069.47%
2021โ‚น88.63-78.21%
2020โ‚น406.77990%
2019โ‚น37.3281.82%
2018โ‚น20.52-113.5%
2017-โ‚น152.070.62%
2016-โ‚น151.1457.28%
2015-โ‚น96.0925.61%
2014-โ‚น76.5018.84%
2013-โ‚น64.37-1085.71%
2012โ‚น6.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น66.24-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น545.93-16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,882 343.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-โ‚น18.66-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น189.39-129.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น483.27-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น704.38-208.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น142.67-78.06%๐Ÿ‡ฌ๐Ÿ‡ง UK